Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Administration for TBI Patients on Aspirin
NCT01135862Phase 2Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Jun 2010
- Primary completion
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of platelets in traumatic brain injury (TBI) (2 arms), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoints: Efficacy of platelet administration in lowering the rate of early hemorrhagic growth at 6 hours and Are lower aspirin doses a risk for early hemorrhagic growth at 6 hours. Status: unknown.
02
Drugs
platelets
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01135862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01135862.